Cargando…

Survival Comparison of Neoadjuvant Chemotherapy Followed by Irreversible Electroporation Versus Conversional Resection for Locally Advanced Pancreatic Cancer

Locally advanced pancreatic cancer (LAPC) is a lethal disease and neoadjuvant chemotherapy and conversional resection is shown to provide the best survival for LAPC patients. Irreversible electroporation (IRE) is a new and effective method for the treatment of LAPC. This study aimed to compare the l...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Chaobin, Sun, Shuxin, Huang, Xin, Zhang, Yu, Lin, Xiaojun, Li, Shengping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884752/ https://www.ncbi.nlm.nih.gov/pubmed/33604301 http://dx.doi.org/10.3389/fonc.2020.622318

Ejemplares similares

Comparison of Survival Between Irreversible Electroporation Followed by Chemotherapy and Chemotherapy Alone for Locally Advanced Pancreatic Cancer
por: He, Chaobin, et al.
Publicado: (2020)

Irreversible Electroporation Plus Anti-PD-1 Antibody versus Irreversible Electroporation Alone for Patients with Locally Advanced Pancreatic Cancer
por: He, Chaobin, et al.
Publicado: (2021)

Irreversible electroporation versus radiotherapy after induction chemotherapy on survival in patients with locally advanced pancreatic cancer: a propensity score analysis
por: He, Chaobin, et al.
Publicado: (2019)

A Novel Prediction Tool Based on Large Cohorts to Determine the Cancer-Specific Survival Probability of Patients With Locally Advanced Pancreatic Cancer After Irreversible Electroporation Treatment
por: He, Chaobin, et al.
Publicado: (2020)

Immunomodulatory Effect after Irreversible Electroporation in Patients with Locally Advanced Pancreatic Cancer
por: He, Chaobin, et al.
Publicado: (2019)

Identification of Circulating Biomarkers and Construction of a Prognostic Signature for Survival Prediction in Locally Advanced Pancreatic Cancer After Irreversible Electroporation
por: He, Chaobin, et al.
Publicado: (2021)

Comparison of combination therapies in the management of locally advanced pancreatic cancer: Induction chemotherapy followed by irreversible electroporation vs radiofrequency ablation
por: He, Chaobin, et al.
Publicado: (2020)

A Novel Nomogram to Predict Survival in Patients With Recurrence of Pancreatic Ductal Adenocarcinoma After Radical Resection
por: He, Chaobin, et al.
Publicado: (2020)

The Synergistic Role of Irreversible Electroporation and Chemotherapy for Locally Advanced Pancreatic Cancer
por: Gyftopoulos, Argyrios, et al.
Publicado: (2022)

T‐cell activation and immune memory enhancement induced by irreversible electroporation in pancreatic cancer
por: He, Chaobin, et al.
Publicado: (2020)

Commentary: The Synergistic Role of Irreversible Electroporation and Chemotherapy for Locally Advanced Pancreatic Cancer
por: Granata, Vincenza, et al.
Publicado: (2022)

Optimizing Patient Selection for Irreversible Electroporation of Locally Advanced Pancreatic Cancer: Analyses of Survival
por: Woeste, Matthew R., et al.
Publicado: (2022)

The role of irreversible electroporation in promoting M1 macrophage polarization via regulating the HMGB1-RAGE-MAPK axis in pancreatic cancer
por: He, Chaobin, et al.
Publicado: (2021)

Score for the Overall Survival Probability of Patients With Pancreatic Adenocarcinoma of the Body and Tail After Surgery: A Novel Nomogram-Based Risk Assessment
por: He, Chaobin, et al.
Publicado: (2020)

Immunomodulatory Effect of Irreversible Electroporation Alone and Its Cooperating With Immunotherapy in Pancreatic Cancer
por: Tian, Guo, et al.
Publicado: (2021)

MR and CT imaging characteristics and ablation zone volumetry of locally advanced pancreatic cancer treated with irreversible electroporation
por: Vroomen, Laurien G. P. H., et al.
Publicado: (2016)

A Quantitative Clinicopathological Signature for Predicting Recurrence Risk of Pancreatic Ductal Adenocarcinoma After Radical Resection
por: He, Chaobin, et al.
Publicado: (2019)

Irreversible electroporation in borderline resectable pancreatic adenocarcinoma for margin accentuation
por: Papoulas, Michail, et al.
Publicado: (2018)

Neoadjuvant chemotherapy for borderline resectable and upfront resectable pancreatic cancer increasing overall survival and disease-free survival?
por: Fossaert, Violette, et al.
Publicado: (2022)

Sequential Irreversible Electroporation for Locally Advanced Pancreatic Cancer
por: Ong, Daniel Yuxuan, et al.
Publicado: (2023)

Neoadjuvant Treatment for Resectable and Borderline Resectable Pancreatic Cancer: Chemotherapy or Chemoradiotherapy?
por: Versteijne, Eva, et al.
Publicado: (2022)

Exploration of Novel Pathways Underlying Irreversible Electroporation Induced Anti-Tumor Immunity in Pancreatic Cancer
por: Imran, Khan Mohammad, et al.
Publicado: (2022)

Case report: Irreversible electroporation for locally advanced pancreatic cancer
por: Orcutt, Sonia, et al.
Publicado: (2017)

High-frequency irreversible electroporation improves survival and immune cell infiltration in rodents with malignant gliomas
por: Campelo, Sabrina N., et al.
Publicado: (2023)

An overview of the irreversible electroporation for the treatment of liver metastases: When to use it
por: Belfiore, Maria Paola, et al.
Publicado: (2022)

Arterial complication of irreversible electroporation procedure for locally advanced pancreatic cancer
por: Ekici, Yahya, et al.
Publicado: (2016)

Outcomes of Neoadjuvant Chemoradiation With and Without Systemic Chemotherapy in Resectable and Borderline Resectable Pancreatic Adenocarcinoma
por: Trinh, Katherine V., et al.
Publicado: (2020)

Treatment of unresectable locally advanced pancreatic cancer with percutaneous irreversible electroporation (IRE) following initial systemic chemotherapy (LAP-PIE) trial: study protocol for a feasibility randomised controlled trial
por: Rai, Zainab L, et al.
Publicado: (2022)

Pain Analysis in Patients with Pancreatic Carcinoma: Irreversible Electroporation versus Cryoablation
por: Li, Jiannan, et al.
Publicado: (2016)

Irreversible electroporation for the treatment of pancreatic neuroendocrine tumors
por: Papamichail, Michail, et al.
Publicado: (2016)

Overall survival and cancer-specific survival in patients with surgically resected pancreatic head adenocarcinoma: A competing risk nomogram analysis
por: He, Chaobin, et al.
Publicado: (2018)

Patient Derived Xenografts Expand Human Primary Pancreatic Tumor Tissue Availability for ex vivo Irreversible Electroporation Testing
por: Brock, Rebecca M., et al.
Publicado: (2020)

CT Findings of Patients Treated with Irreversible Electroporation for Locally Advanced Pancreatic Cancer
por: Akinwande, Olaguoke, et al.
Publicado: (2015)

Systematic Review of Irreversible Electroporation Role in Management of Locally Advanced Pancreatic Cancer
por: Lafranceschina, Stefano, et al.
Publicado: (2019)

Irreversible electroporation combined with chemotherapy for unresectable pancreatic carcinoma: a prospective cohort study
por: Liu, Shupeng, et al.
Publicado: (2019)

Survival and complications after neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for locally advanced gastric cancer: a systematic review and meta-analysis
por: Zhu, Youqi, et al.
Publicado: (2023)

A Single-institution Experience with Open Irreversible Electroporation for Locally Advanced Pancreatic Carcinoma
por: Yan, Li, et al.
Publicado: (2016)

Simultaneous Gemcitabine and Percutaneous CT-Guided Irreversible Electroporation for Locally Advanced Pancreatic Cancer
por: Ma, Yangyang, et al.
Publicado: (2022)

Neoadjuvant Sintilimab Plus Chemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
por: Lv, Huilai, et al.
Publicado: (2022)

Conversiones electromecánicas : máquinas de c.c. y de c.a.
por: Poloujadoff, Michel, 1932-
Publicado: (1974)

Cannot write session to /tmp/vufind_sessions/sess_t6cc3b39ef9stapoprsv22qtq6